Opportunistic Infections Citation List: July 3 - July 16, 2015

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

1. Phenylbutyrate is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-vitamin D(3). Coussens, A.K., R.J. Wilkinson, and A.R. Martineau. Plos Pathogens, 2015. 11(7): p. e1005007. PMID[26133770].

[PubMed]. OI_0703-071615.

2. Lansoprazole is an Antituberculous Prodrug Targeting Cytochrome bc1. Rybniker, J., A. Vocat, C. Sala, P. Busso, F. Pojer, A. Benjak, and S.T. Cole. Nature Communications, 2015. 6(7659): 8pp. PMID[26158909].

[PubMed]. OI_0703-071615

Citations from the ISI Web of Knowledge Listings for O.I.

3. Isocitrate Lyase of Mycobacterium tuberculosis Is Inhibited by Quercetin through Binding at N-terminus. Shukla, H., V. Kumar, A.K. Singh, S. Rastogi, S.R. Khan, M.I. Siddiqi, M.Y. Krishnan, and M.S. Akhtar. International Journal of Biological Macromolecules, 2015. 78: p. 137-141. ISI[000356195400018].

[WOS]. OI_0703-071615.

4. Generation of Broad-spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A. Wuts, P.G.M., L.J. Simons, B.P. Metzger, R.C. Sterling, J.L. Slightom, and A.P. Elhammer. ACS Medicinal Chemistry Letters, 2015. 6(6): p. 645-649. ISI[000356320300005].

[WOS]. OI_0703-071615.